Cargando…
Treatment Success in Cancer: Industry Compared to Publicly Sponsored Randomized Controlled Trials
OBJECTIVE: To assess if commercially sponsored trials are associated with higher success rates than publicly-sponsored trials. STUDY DESIGN AND SETTINGS: We undertook a systematic review of all consecutive, published and unpublished phase III cancer randomized controlled trials (RCTs) conducted by G...
Autores principales: | Djulbegovic, Benjamin, Kumar, Ambuj, Miladinovic, Branko, Reljic, Tea, Galeb, Sanja, Mhaskar, Asmita, Mhaskar, Rahul, Hozo, Iztok, Tu, Dongsheng, Stanton, Heather A., Booth, Christopher M., Meyer, Ralph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605423/ https://www.ncbi.nlm.nih.gov/pubmed/23555593 http://dx.doi.org/10.1371/journal.pone.0058711 |
Ejemplares similares
-
Benchmarks for detecting ‘breakthroughs’ in clinical trials: empirical assessment of the probability of large treatment effects using kernel density estimation
por: Miladinovic, Branko, et al.
Publicado: (2014) -
Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis
por: Wao, Hesborn, et al.
Publicado: (2013) -
Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-compliance
por: Miladinovic, Branko, et al.
Publicado: (2011) -
A Flexible Alternative to the Cox Proportional Hazards Model for Assessing the Prognostic Accuracy of Hospice Patient Survival
por: Miladinovic, Branko, et al.
Publicado: (2012) -
How do physicians decide to treat: an empirical evaluation of the threshold model
por: Djulbegovic, Benjamin, et al.
Publicado: (2014)